Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Given PillCam ESO Reimbursed In Israel; U.S. Data Collection Underway

This article was originally published in The Gray Sheet

Executive Summary

Given Imaging plans to take an incremental approach to garnering reimbursement for its PillCam ESO video capsule system, focusing initially on esophageal varices diagnosis coverage

You may also be interested in...



Given Imaging Eyes Japan, Expanded Reimbursement For PillCam Capsules

Given Imaging plans to aggressively launch the PillCam SB endoscopy video capsule in Japan this year, following approval from the Ministry of Health, Labor & Welfare

Given Imaging Esophageal PillCam Video Capsule Clearance Aids Stock Gain

FDA clearance of Given Imaging's PillCam ESO 14-frame-per-second endoscopy video capsule for esophageal imaging Nov. 29 resulted in a 3.3% stock gain to $33.31 for the month

ICER Partnering With Aetion To Scale Up Use Of RWE In Value Assessments

Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.

UsernamePublicRestriction

Register

MT021868

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel